Skip to Main Content

Author Details

Anil Bamezai
Villanova University
1988
48
22
PMIDPaper TitleJournal TitlePublished Year
36725744Ly-6A-Induced Growth Inhibition and Cell Death in a Transformed CD4<sup>+</sup> T Cell Line: Role of Tumor Necrosis Factor-α.Arch Immunol Ther Exp (Warsz)2023
37141412Human <i>LY6</i> gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.Oncotarget2023
35813207Editorial: Biology of Ly-6 Supergene Family in Health and Disease.Front Cell Dev Biol2022
33480049Nonviral gene delivery to T cells with Lipofectamine LTX.Biotechnol Bioeng2021
34234214Cholesterol-dependent plasma membrane order (L<sub>o</sub>) is critical for antigen-specific clonal expansion of CD4<sup>+</sup> T cells.Sci Rep2021
28660664Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4<sup>+</sup> T-cell lines.Immun Inflamm Dis2017
27322740Investigating B Cell Development, Natural and Primary Antibody Responses in Ly-6A/Sca-1 Deficient Mice.PLoS One2016
25494999Lipid raft-based membrane order is important for antigen-specific clonal expansion of CD4(+) T lymphocytes.BMC Immunol2014
22281104In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4(+) T cells.Vaccine2012
22151974Analysis of detergent-free lipid rafts isolated from CD4+ T cell line: interaction with antigen presenting cells promotes coalescing of lipid rafts.Cell Commun Signal2011
20074367The relationship between safety net activities and hospital financial performance.BMC Health Serv Res2010
18778202Interferon gamma enhances clonal expansion and survival of CD4+ T cells.J Interferon Cytokine Res2008
19082945Cell-free antibody capture method for analysis of detergent-resistant membrane rafts.Methods Mol Biol2008
16403754Evidence of cost shifting in California hospitals.Health Aff (Millwood)2006
16932135Marginal cost of emergency department outpatient visits: an update using California data.Med Care2006
16519737A novel approach to examining compositional heterogeneity of detergent-resistant lipid rafts.Immunol Cell Biol2006
15855942The cost of an emergency department visit and its relationship to emergency department volume.Ann Emerg Med2005
15451985Hospital emergency departments: the authors respond.Health Aff (Millwood)2004
15467490Mouse Ly-6 proteins and their extended family: markers of cell differentiation and regulators of cell signaling.Arch Immunol Ther Exp (Warsz)2004
15333125The effect of HMOs on the inpatient utilization of medicare beneficiaries.Health Serv Res2004
15451990Emergency department capacity and access in California, 1990-2001: an economic analysis.Health Aff (Millwood)2004
12722762Hospital selective contracting without consumer choice: what can we learn from Medi-Cal?J Policy Anal Manage2003
12889992Loss of Ly-6A.2 expression on immature developing T cells in the thymus is necessary for their normal growth and generation of the Vbeta T-cell repertoire.Tissue Antigens2003
11751954Ly-6A.2 expression regulates antigen-specific CD4+ T cell proliferation and cytokine production.J Immunol2002
12052258Hospital competition, resource allocation and quality of care.BMC Health Serv Res2002
11589307Downregulated expression of Ly-6-ThB on developing T cells marks CD4+CD8+ subset undergoing selection in the thymus.Dev Immunol2001
10790700Can cost shifting continue in a price competitive environment?Health Econ2000
11055452The effect of selective contracting on hospital costs and revenues.Health Serv Res2000
11034381A monoclonal antibody against the 66-kDa protein expressed in mouse spleen and thymus inhibits Ly-6A.2-dependent cell-cell adhesion.J Immunol2000
10348418Price competition and hospital cost growth in the United States (1989-1994).Health Econ1999
9647222CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.J Immunol1998
9248168A profile of uncompensated hospital care, 1983-1995.Health Aff (Millwood)1997
7657212Uncompensated care: hospitals' responses to fiscal pressures.Health Aff (Millwood)1995
10163099Managing the safety net: hospital provision of uncompensated care in response to managed care.Adv Health Econ Health Serv Res1995
7753800Overexpressed Ly-6A.2 mediates cell-cell adhesion by binding a ligand expressed on lymphoid cells.Proc Natl Acad Sci U S A1995
7722283Regulated expression of Ly-6A.2 is important for T cell development.J Immunol1995
7988988Costs and price competition in California hospitals, 1980-1990.Health Aff (Millwood)1994
8081241A role of Ly-6A.2 in T lymphocyte activation and development.Braz J Med Biol Res1994
1346109Internalization of glycosyl-phosphatidylinositol (GPI)-anchored lymphocyte proteins. II. GPI-anchored and transmembrane molecules internalize through distinct pathways.Eur J Immunol1992
10122537The effects of market structure and bargaining position on hospital prices.J Health Econ1992
1679532Effect of ras-activation on the expression of glycosyl-phosphatidylinositol-anchored proteins on the plasma membrane.Oncogene1991
1904518Using DRGs to pay for inpatient substance abuse services: an assessment of the CHAMPUS reimbursement system.Med Care1991
2620075Role of adjuvants in inhibitory influence of immunization with porcine zona pellucida antigen (ZP-3) on ovarian folliculogenesis in bonnet monkeys: a morphological study.Biol Reprod1989
2572642Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.J Immunol1989
2697681The LY-6 locus: a multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation.Immunol Rev1989
2894252TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor.Cell1988
2842394T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP.J Immunol1988
3418620Inhibition of penetration of canine zonae pellucidae by homologous spermatoza in vitro using monoclonal antibodies raised against porcine zonae.J Reprod Immunol1988
  • 1 - 48 of 48

Recommended Authors

Jeremy J Rose
National Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Erik J Peterson
University of California
Career Start Year 1996
Number of shared co-authors 0
Chance John Luckey
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 0
Manish J Butte
University of California Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Anna Maria Masci
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Peter W Marks
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 0
Kanury V S Rao
Translational Health Science and Technology Institute
Career Start Year 1987
Number of shared co-authors 0
Hiroshi Ohno
RIKEN Center for Integrative Medical Sciences
Career Start Year 1986
Number of shared co-authors 0
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 0
George F Tidmarsh
La Jolla Pharmaceutical Company
Career Start Year 1983
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Penelope A Morel
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
David R Karp
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 0
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 0
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 0
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 0
Daniel W McVicar
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 0
Peter A Kiener
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
Ira Mellman
Genentech Inc.
Career Start Year 1974
Number of shared co-authors 0
Katherine A Siminovitch
University of Toronto, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1974
Number of shared co-authors 0
Arthur Weiss
University of California san francisco
Career Start Year 1972
Number of shared co-authors 0
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 0
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Deborah Palliser
Albert Einstein College of Medicine
Co-authored papers 2
Jeffrey T McGrew
Co-authored papers 2
Clay Chappell
Co-authored papers 1
Justin T Reese
Lawrence Berkeley National Laboratory
Co-authored papers 1
Julie M Miwa
Lehigh University.
Co-authored papers 1
Susan D Hosek
Co-authored papers 1
Hitesh K Mehta
St Michael's Hospital, University of Toronto
Co-authored papers 1
Release 1.2